Larvol Delta - Selectively-Targeting-Tumor-Hypoxia-with-the-HypoxiaActivated-Prodrug-CP506

CP-506 - Convert Pharma

http://www.ncbi.nlm.nih.gov/pubmed/34625504

Oct 10, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next